tiprankstipranks
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
PremiumPress ReleasesAmarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
13d ago
Amarin to present research on benefits of VASCEPA/VAZKEPA
PremiumThe Fly
Amarin to present research on benefits of VASCEPA/VAZKEPA
22d ago
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
PremiumPress Releases
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
22d ago
Amarin reports Q4 EPS 0c, consensus (3c)
PremiumThe FlyAmarin reports Q4 EPS 0c, consensus (3c)
2M ago
Options Volatility and Implied Earnings Moves Today, February 29, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, February 29, 2024
2M ago
Amarin Corporation Plc (AMRN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Amarin Corporation Plc (AMRN) Q4 Earnings Cheat Sheet
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Amarin Regains Compliance, Maintains NASDAQ Listing
PremiumMarket News
Amarin Regains Compliance, Maintains NASDAQ Listing
3M ago
Amarin Chairman & CEO Issue Letter to Shareholders
PremiumPress Releases
Amarin Chairman & CEO Issue Letter to Shareholders
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100